<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(4)</volume><submitter>de Maleprade B</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>To describe the joint manifestations associated with clonal haematopoiesis and to compare patients with and without VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome.&lt;h4>Methods&lt;/h4>Patients screened for &lt;i>UBA1&lt;/i> mutations between December 2019 and January 2023 in 7 Normandie (France) hospitals were recruited retrospectively.&lt;h4>Results&lt;/h4>Thirty patients with a haematological disorder associated with dysimmune manifestations were included: 17 (57%) without &lt;i>UBA1&lt;/i> mutations (non-VEXAS) and 13 (43%) with &lt;i>UBA1&lt;/i> mutations (VEXAS). Thirteen (77%) non-VEXAS patients had joint involvement (arthralgia/arthritis), compared with 4 (31%) VEXAS patients (p value: 0.016). Unsupervised clustering using hierarchical clustering identified two clust</pubmed_abstract><journal>RMD open</journal><pagination>e006074</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12574337</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Joint involvement in VEXAS and non-VEXAS clonal haematopoiesis: two clusters from a multicentre regional cohort.</pubmed_title><pmcid>PMC12574337</pmcid><pubmed_authors>Stamatoullas-Bastard A</pubmed_authors><pubmed_authors>Langlois V</pubmed_authors><pubmed_authors>Jastrzebski F</pubmed_authors><pubmed_authors>Sauvetre G</pubmed_authors><pubmed_authors>Armengol G</pubmed_authors><pubmed_authors>Avenel M</pubmed_authors><pubmed_authors>Lequerre T</pubmed_authors><pubmed_authors>de Maleprade B</pubmed_authors><pubmed_authors>Benhamou Y</pubmed_authors><pubmed_authors>Jardin F</pubmed_authors><pubmed_authors>Brevet P</pubmed_authors><pubmed_authors>Vittecoq O</pubmed_authors><pubmed_authors>Curie A</pubmed_authors><pubmed_authors>Membrey B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Joint involvement in VEXAS and non-VEXAS clonal haematopoiesis: two clusters from a multicentre regional cohort.</name><description>&lt;h4>Objective&lt;/h4>To describe the joint manifestations associated with clonal haematopoiesis and to compare patients with and without VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome.&lt;h4>Methods&lt;/h4>Patients screened for &lt;i>UBA1&lt;/i> mutations between December 2019 and January 2023 in 7 Normandie (France) hospitals were recruited retrospectively.&lt;h4>Results&lt;/h4>Thirty patients with a haematological disorder associated with dysimmune manifestations were included: 17 (57%) without &lt;i>UBA1&lt;/i> mutations (non-VEXAS) and 13 (43%) with &lt;i>UBA1&lt;/i> mutations (VEXAS). Thirteen (77%) non-VEXAS patients had joint involvement (arthralgia/arthritis), compared with 4 (31%) VEXAS patients (p value: 0.016). Unsupervised clustering using hierarchical clustering identified two clust</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-05T07:34:45.188Z</modification><creation>2026-05-14T03:12:36.566Z</creation></dates><accession>S-EPMC12574337</accession><cross_references><pubmed>41167634</pubmed><doi>10.1136/rmdopen-2025-006074</doi></cross_references></HashMap>